Metabolic myopathies

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

Original languageEnglish (US)
Title of host publicationPrimer on the Rheumatic Diseases: Thirteenth Edition
PublisherSpringer New York
Pages381-388
Number of pages8
ISBN (Print)9780387356648
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Muscular Diseases
Mitochondrial Myopathies
Glycogen Storage Disease
Oxidative Phosphorylation
Glycogen
Lipid Metabolism
Electrolytes
Skeletal Muscle
Lipids
Muscles
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Baer, A. (2008). Metabolic myopathies. In Primer on the Rheumatic Diseases: Thirteenth Edition (pp. 381-388). Springer New York. https://doi.org/10.1007/978-0-387-68566-3_19

Metabolic myopathies. / Baer, Alan.

Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, 2008. p. 381-388.

Research output: Chapter in Book/Report/Conference proceedingChapter

Baer, A 2008, Metabolic myopathies. in Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, pp. 381-388. https://doi.org/10.1007/978-0-387-68566-3_19
Baer A. Metabolic myopathies. In Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York. 2008. p. 381-388 https://doi.org/10.1007/978-0-387-68566-3_19
Baer, Alan. / Metabolic myopathies. Primer on the Rheumatic Diseases: Thirteenth Edition. Springer New York, 2008. pp. 381-388
@inbook{c1f961d15ec14721bee6d36c3acf70c8,
title = "Metabolic myopathies",
abstract = "The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.",
author = "Alan Baer",
year = "2008",
doi = "10.1007/978-0-387-68566-3_19",
language = "English (US)",
isbn = "9780387356648",
pages = "381--388",
booktitle = "Primer on the Rheumatic Diseases: Thirteenth Edition",
publisher = "Springer New York",

}

TY - CHAP

T1 - Metabolic myopathies

AU - Baer, Alan

PY - 2008

Y1 - 2008

N2 - The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

AB - The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

UR - http://www.scopus.com/inward/record.url?scp=84892276861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892276861&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68566-3_19

DO - 10.1007/978-0-387-68566-3_19

M3 - Chapter

AN - SCOPUS:84892276861

SN - 9780387356648

SP - 381

EP - 388

BT - Primer on the Rheumatic Diseases: Thirteenth Edition

PB - Springer New York

ER -